Aug. 16 at 10:47 PM
$HUBC Mark your calendars for the meeting on September 8th when they approve the Evofem deal with the associated massive dilution priced at less than 9 cents. If the price holds and these shysters pump, those Evofem note holders will make a small fortune. Just in time to also approve the 4th split for 2026. 😉
https://www.sec.gov/Archives/edgar/data/1905660/000121390026085224/ea030061201ex99-1.htm
4. To authorize our Board to effect one or more reverse share splits of our ordinary shares, no par value (“Ordinary Shares”), with an aggregate ratio in the range of 1-for-5 to 1-for-1,000,...
5. To approve an increase in the Company’s authorized share capital, from sixty-six million six hundred sixty-six thousand six hundred sixty-six (66,666,666) Ordinary Shares to one billion (1,000,000,000) Ordinary Shares...
6. To approve the private placement of Ordinary Shares and pre-funded warrants to purchase Ordinary Shares to the sellers of certain notes and purchase rights to acquire securities of Evofem Biosciences, Inc., ...
